Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients.
Lindahl
A K
AK
Hematological Research Laboratory, Aker Hospital, University of Oslo, Norway.
Abildgaard
U
U
Stokke
G
G
D000368:Aged; D004730:Endothelium, Vascular / Q000378:metabolism; D005167:Factor VII / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000503:physiopathology; D009369:Neoplasms / Q000097:blood / Q000378:metabolism*; D013925:Thromboplastin / Q000037:antagonists & inhibitors* / Q000378:metabolism
D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor; D005167:Factor VII; D006493:Heparin; D013925:Thromboplastin